SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001047469-19-006334
Filing Date
2019-11-15
Accepted
2019-11-15 17:12:21
Documents
9

Document Format Files

Seq Description Document Type Size
1 S-3 a2239784zs-3.htm S-3 269402
2 EX-4.4 a2239784zex-4_4.htm EX-4.4 490376
3 EX-4.6 a2239784zex-4_6.htm EX-4.6 144590
4 EX-4.7 a2239784zex-4_7.htm EX-4.7 144700
5 EX-4.8 a2239784zex-4_8.htm EX-4.8 131996
6 EX-5.1 a2239784zex-5_1.htm EX-5.1 30624
7 EX-23.1 a2239784zex-23_1.htm EX-23.1 3259
8 G348071.JPG g348071.jpg GRAPHIC 16120
9 G191182KSI001.GIF g191182ksi001.gif GRAPHIC 1275
  Complete submission text file 0001047469-19-006334.txt   1240274
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Filer) CIK: 0000827871 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-234742 | Film No.: 191225314
SIC: 2834 Pharmaceutical Preparations